Testing effectiveness (Phase 2)Ended earlyNCT06833281What this trial is testingExtension Study of Participants From SPG302-ALZ-101Who this might be right forAlzheimer's Disease Spinogenix 12
Testing effectiveness (Phase 2)Study completedNCT01735630What this trial is testingEfficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseWho this might be right forAlzheimer's Disease OPKO Health, Inc. 350
Not applicableStudy completedNCT03060200What this trial is testingReducing Depressive Symptomatology With a Smartphone AppWho this might be right forModerate Depression Babes-Bolyai University 158
Testing effectiveness (Phase 2)Ended earlyNCT02249351What this trial is testingEfficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer TypeWho this might be right forAlzheimer Disease Boehringer Ingelheim 54
Not applicableStudy completedNCT02711683What this trial is testingDL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving DonepezilWho this might be right forAlzheimer's Disease First Affiliated Hospital Xi'an Jiaotong University 92
Large-scale testing (Phase 3)WithdrawnNCT04187547What this trial is testingA Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label ExtensionWho this might be right forAlzheimer's Disease Cerecin
Large-scale testing (Phase 3)Ended earlyNCT01066546What this trial is testingAn Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 5
Testing effectiveness (Phase 2)Study completedNCT04079803What this trial is testingPTI-125 for Mild-to-moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer Disease Cassava Sciences, Inc. 64
Large-scale testing (Phase 3)WithdrawnNCT00743743What this trial is testingPilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT00810147What this trial is testingA Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Bristol-Myers Squibb 209
Not applicableStudy completedNCT02007291What this trial is testingGood Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of TreatmentWho this might be right forLate Onset Alzheimer Federal University of Minas Gerais 71
Testing effectiveness (Phase 2)Study completedNCT00663026What this trial is testingStudy Evaluating Bapineuzumab In Alzheimer Disease SubjectsWho this might be right forAlzheimer Disease Pfizer 79
Large-scale testing (Phase 3)Study completedNCT02293915What this trial is testingAn Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's DiseaseWho this might be right forMild to Moderate Alzheimer DiseaseCognitive Impairment Shanghai Greenvalley Pharmaceutical Co., Ltd. 818
Large-scale testing (Phase 3)Study completedNCT00428090What this trial is testingRosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 862
Testing effectiveness (Phase 2)Study completedNCT03069014What this trial is testingStudy of LM11A-31-BHS in Mild-moderate AD PatientsWho this might be right forMild to Moderate Alzheimer's Disease PharmatrophiX Inc. 242
Large-scale testing (Phase 3)Ended earlyNCT00676143What this trial is testingStudy Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease PatientsWho this might be right forAlzheimer Disease Pfizer 1,100
Early research (Phase 1)Study completedNCT00495417What this trial is testingTolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Affiris AG 24
Testing effectiveness (Phase 2)Study completedNCT00710684What this trial is testingSB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 682
Not applicableStudy completedNCT01478204What this trial is testingEvaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Janssen-Cilag, S.A. 925
Very early researchStudy completedNCT03577262What this trial is testingA Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic DensityWho this might be right forHealthyAlzheimer Disease Alkermes, Inc. 19